These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 11200379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Postantifungal effect and effects of sub-MIC concentrations on previously treated Candida sp. influence of growth phase.
    García MT, Llorente MT, Mínguez F, Prieto J.
    J Infect; 2002 Nov; 45(4):263-7. PubMed ID: 12423615
    [Abstract] [Full Text] [Related]

  • 3. Post-antifungal effect and effects of sub-MIC concentrations on previously treated Candida spp.: influence of exposure time and concentration.
    García MT, Llorente MT, Mínguez F, Prieto J.
    Scand J Infect Dis; 2002 Nov; 34(3):197-200. PubMed ID: 12030393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
    Ellepola AN, Samaranayake LP.
    Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S, Ellepola AN, Samaranayake LP.
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The postantifungal effect (PAFE) of itraconazole, in comparison with those of miconazole and fluconazole, on Candida Species.
    Uchida K, Abe S, Yamaguchi H.
    Microbiol Immunol; 2006 Sep; 50(9):679-85. PubMed ID: 16985289
    [Abstract] [Full Text] [Related]

  • 15. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
    Zhanel GG, Saunders DG, Hoban DJ, Karlowsky JA.
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
    [Abstract] [Full Text] [Related]

  • 16. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN.
    Med Princ Pract; 2012 Jul; 21(5):442-6. PubMed ID: 22678101
    [Abstract] [Full Text] [Related]

  • 17. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans.
    Ellepola AN, Khajah R, Jayatilake S, Samaranayake L, Sharma P, Khan Z.
    J Appl Oral Sci; 2015 Jul; 23(4):412-8. PubMed ID: 26398514
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G, Manzara S, Dettori G.
    Chemotherapy; 1991 Jul; 37(1):23-31. PubMed ID: 2013239
    [Abstract] [Full Text] [Related]

  • 19. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
    Samaranayake YH, Yau JY, Thein ZM, Jayatilake JA, Yeung KW, Samaranayake LP.
    Med Mycol; 2010 Aug; 48(5):725-34. PubMed ID: 20092419
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.